These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17763487)

  • 1. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
    Ouberai M; Dumy P; Chierici S; Garcia J
    Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-peptide conjugates for binding beta-amyloid plaques of Alzheimer's disease.
    Zhang G; Leibowitz MJ; Sinko PJ; Stein S
    Bioconjug Chem; 2003; 14(1):86-92. PubMed ID: 12526697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions of dendrimers with amyloid peptides: pH dependence.
    Klajnert B; Cladera J; Bryszewska M
    Biomacromolecules; 2006 Jul; 7(7):2186-91. PubMed ID: 16827586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide inhibitors of beta-amyloid aggregation.
    Doig AJ
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):533-9. PubMed ID: 17786851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
    Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
    Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
    Moss MA; Nichols MR; Reed DK; Hoh JH; Rosenberry TL
    Mol Pharmacol; 2003 Nov; 64(5):1160-8. PubMed ID: 14573766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
    Gibson TJ; Murphy RM
    Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of amyloid beta peptide-binding proteins: pseudo-Abeta beta-sheet surface presented in green fluorescent protein binds tightly and preferentially to structured Abeta.
    Takahashi T; Ohta K; Mihara H
    Proteins; 2010 Feb; 78(2):336-47. PubMed ID: 19731370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G; Ruchala P; Teplow DB
    Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage display affords peptides that modulate beta-amyloid aggregation.
    Orner BP; Liu L; Murphy RM; Kiessling LL
    J Am Chem Soc; 2006 Sep; 128(36):11882-9. PubMed ID: 16953628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
    Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.
    Etienne MA; Aucoin JP; Fu Y; McCarley RL; Hammer RP
    J Am Chem Soc; 2006 Mar; 128(11):3522-3. PubMed ID: 16536517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
    Chen Z; Krause G; Reif B
    J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.
    Schwarzman AL; Tsiper M; Gregori L; Goldgaber D; Frakowiak J; Mazur-Kolecka B; Taraskina A; Pchelina S; Vitek MP
    Amyloid; 2005 Dec; 12(4):199-209. PubMed ID: 16399644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.
    Rangachari V; Davey ZS; Healy B; Moore BD; Sonoda LK; Cusack B; Maharvi GM; Fauq AH; Rosenberry TL
    Biopolymers; 2009 Jun; 91(6):456-65. PubMed ID: 19189374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.